0001250853-14-000075.txt : 20140516
0001250853-14-000075.hdr.sgml : 20140516
20140516203351
ACCESSION NUMBER: 0001250853-14-000075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140515
FILED AS OF DATE: 20140516
DATE AS OF CHANGE: 20140516
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lion Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001425205
STANDARD INDUSTRIAL CLASSIFICATION: ARRANGEMENT OF TRANSPORTATION OF FREIGHT & CARGO [4731]
IRS NUMBER: 753254381
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21900 BURBANK BLVD.
STREET 2: THIRD FLOOR
CITY: WOODLAND HILLS
STATE: CA
ZIP: 91367
BUSINESS PHONE: 818-992-3126
MAIL ADDRESS:
STREET 1: 21900 BURBANK BLVD.
STREET 2: THIRD FLOOR
CITY: WOODLAND HILLS
STATE: CA
ZIP: 91367
FORMER COMPANY:
FORMER CONFORMED NAME: Genesis Biopharma, Inc
DATE OF NAME CHANGE: 20100319
FORMER COMPANY:
FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP
DATE OF NAME CHANGE: 20080128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Handelman Michael D
CENTRAL INDEX KEY: 0001299390
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53127
FILM NUMBER: 14853047
MAIL ADDRESS:
STREET 1: 21900 BURBANK BLVD, THIRD FLOOR
CITY: WOODLAND HILLS
STATE: CA
ZIP: 91367
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2014-05-15
0
0001425205
Lion Biotechnologies, Inc.
LBIO
0001299390
Handelman Michael D
21900 BURBANK BLVD, THIRD FLOOR
WOODLAND HILLS
CA
91367
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
7.95
2014-05-15
4
A
0
75000
0
A
2019-05-14
Common Stock
75000
75000
D
Restricted Stock Units
0
2014-05-15
4
A
0
75000
0
A
Common Stock
75000
75000
D
The option will vest as to 25,000 shares on May 15, 2015 and the remaining shares shall vest in equal quarterly installments over the next two years following May 15, 2015, provided the Reporting Person remains in continuous employ of the Issuer.
The option will vest as to (i) 25,000 shares on May 15, 2015, provided, however, that this vesting date will accelerate and change to August 15, 2014 if the Issuer has timely filed the quarterly reports of Form 10-Q for the fiscal quarters ended March 31, 2014 and June 30, 2014 and (ii) 25,000 shares shall vest on each of May 15, 2016 and May 15, 2017, provided the Reporting Person remains in continuous employ of the Issuer.
/s/ Michael Handelman
2014-05-16